請用此 Handle URI 來引用此文件: http://hdl.handle.net/11455/40347
標題: Combined differential gene expression profile and pathway enrichment analyses to elucidate the molecular mechanisms of uterine leiomyoma after gonadotropin-releasing hormone treatment
作者: Chen, H.W.
陳健尉
Liu, J.C.C.
Chen, J.J.W.
Lee, Y.M.
Hwang, J.L.
Tzeng, C.R.
關鍵字: cdna microarray
analog therapy
cell-proliferation
human myometrium
pathogenesis
fibroids
inhibitor
etiology
axis
期刊/報告no:: Fertility and Sterility, Volume 90, Issue 4, Page(s) 1219-1225.
摘要: Composite regulatory signature database (CRSD), a self-developed comprehensive Web server for composite regulatory signature discovery, used to compare the published microarray data with our data on patients with uterine leiomyoma treated with or without GnRH analogue (GnRH-a), revealed that the focal adhesion, mitogen-activated protein kinase (MAPK), CXC chemokine receptor 4/stromal-derived factor-1 (CXCR4/SDF-1), T-cell receptor, integrin, vascular endothelial growth factor (VEGF), GnRH, and transforming growth factor-beta (TGF-beta) signaling pathways are highly expressed in uterine leiomyoma and significantly down-regulated after GnRH-a treatment. According to the results these signaling pathways could be involved in inflammation, proliferation, and remodeling processes of leiomyoma development and possibly in the regression of leiomyoma after GnRH-a treatment, which might improve our understanding of the mechanisms of leiomyoma formation and help us to find novel drug targets or specific markers for diagnosis and prognosis in uterine leiomyoma.
URI: http://hdl.handle.net/11455/40347
ISSN: 0015-0282
文章連結: http://dx.doi.org/10.1016/j.fertnstert.2007.11.015
顯示於類別:生物醫學研究所

文件中的檔案:
沒有與此文件相關的檔案。


在 DSpace 系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。